Herbert Smith Freehills

NOVEMBER 18, 2022

Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a strategic partnership with PT Kimia Farma Tbk, jointly with Indonesia Investment Authority (INA).

Marketing 52

Marketing Marketing Publishing Law 52

Intellectual Property Law Blog

OCTOBER 30, 2023

The NIST standards will likely build on its prior work as published in its AI Risk Management Framework Biological synthesis screening – to protect against the risks of using AI to engineer dangerous biological materials, strong new standards for biological synthesis screening will be developed by agencies that fund life-science projects as a condition (..)

Privacy 130

Privacy Government Copyright Technology 130

LexBlog IP

MAY 1, 2023

In March 2023, the House Ways and Means Committee hosted an investigative hearing on “private equity’s expanded role in the US healthcare system” As you might expect from a federal investigation, conducted by politicians with media present, the tone of the meeting was more hostile rather than supportive.

Ownership 52

Ownership Business Publishing Government 52

Velocity of Content

MARCH 7, 2023

The CAP model, which is also supported by CCC RightsLink for Scientific Communications (RLSC), eliminates author Article Publishing Charges (APCs) and makes PLOS journals truly Open to Read and Open to Publish.

Publishing 98

Publishing Journalism Government Marketing 98

IP Watchdog

JUNE 21, 2022

Accord Healthcare, Inc. Senior Circuit Judge Richard Linn authored a dissent arguing that the panel majority had improperly adopted a heightened written description standard and failed to take into account expert testimony from Novartis regarding a negative claim limitation that the district court found was supported by ample evidence.

Patent 59

Patent Litigation Intellectual Property IP 59

SpicyIP

AUGUST 23, 2023

[ This guest post is authored by our former blogger Varsha Jhavar and Surbhi Nautiyal. The views expressed here are those of the authors’ alone.] In Part I of the post, the authors have analysed the National Policy on Rare Diseases, 2021 (Policy) and its implementation. Further, the Govt.

Government 98

Government Marketing Marketing IP 98

IP and Legal Filings

MARCH 8, 2024

This dichotomy results from the complexities involved in drawing boundaries between the authority of local self-governance institutions and the federal government. These overlaps can be in various areas such as Education, Healthcare, Planning and several other regulations. 280(3)(bb).

Government 86

Government Art IP 86

Velocity of Content

MAY 2, 2023

Linguamatics has been serving the healthcare and pharma space for many years. In a recent blog post you talk about the “healthcare data revolution.” Can you give us a brief explainer of what’s happening in the industry – and how Linguamatics is responding? Many sources of real-world data contain large amounts of unstructured text (e.g.

Social Media 98

Social Media Technology Blogging Business 98

Patently-O

AUGUST 25, 2022

Accord Healthcare, Inc., Accord Healthcare, Inc. , Accord Healthcare, Inc. , That original opinion had been authored by Judge O’Malley with Chief Judge Moore in dissent. 4th 1013 (Fed. 2022), the Federal Circuit made a procedurally embarrassing rehearing decision. Novartis Pharm. 4th 1362 (Fed. 4th 1362 (Fed.

Government 78

Government Patent Trademark 78

LexBlog IP

JULY 21, 2023

On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application (MAA) for DMB-3115, a biosimilar referencing STELARA (ustekinumab). Intas Pharmaceuticals’ subsidiary Accord Healthcare will commercialize the product in the EU, UK, and Canada.

Licensing 52

Licensing Marketing Marketing Intellectual Property 52

IP Intelligence

SEPTEMBER 20, 2023

What gets decided in the next six months to a year about artificial intelligence (AI) legislation, and regulatory action on copyrights and AI, will apply with equal force to AI uses in healthcare, energy and other industries as it does to a consumer using Midjourney to make a birthday card. 30, the U.S.

Fair Use 111

Fair Use Public Domain Copyright Ownership 111

The IPKat

MARCH 2, 2022

While personalized medicine seems to be an essential of modern healthcare, it is also rather unclear how innovations that are developed for its purposes align with patentability requirements and, in general, the way the patent system operates. Join us and discuss this very interesting subject! He teaches European, U.S

Intellectual Property 95

Intellectual Property Intellectual Property Law IP Patent Law 95

LexBlog IP

JULY 1, 2022

On June 23, 2022, CHMP recommended the grant of a marketing authorization for RANIVISIO (ranibizumab) to Midas Pharma GmbH. On the same day, CHMP also recommended grant of a marketing authorization for VEGZELMA (bevacizumab) to Celltrion Healthcare Hungary Kft. RANIVISIO will be available as a 10 mg/ml solution for injection.

Marketing 52

Marketing Marketing Licensing Reporting 52

LexBlog IP

JANUARY 25, 2023

On January 24, Alvotech and Bioventure, a subsidiary of GlobalOne Healthcare Holding LLC, announced that the Saudi Food & Drug Authority has approved SIMLANDI, a biosimilar referencing HUMIRA (adalimumab), in Saudi Arabia.

Reporting 52

Reporting Intellectual Property 52

LexBlog IP

NOVEMBER 20, 2023

Biocon Biologics receives approval in the UK for Aflibercept biosimilar : On November 13, 2023, Biocon Biologics Limited announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for YESAFILI, a biosimilar aflibercept.

Marketing 52

Marketing Marketing Licensing Intellectual Property 52

LexBlog IP

MAY 19, 2022

(Teva) announced that the UK Medicines & Healthcare Regulatory Agency (MHRA) approved ONGAVIA, a ranibizumab biosimilar referencing Genentech’s LUCENTIS. The United Kingdom is the first country in Europe to authorize commercialization of ONGAVIA for the treatment of neovascular (wet) age-related macular degeneration (AMD).

Licensing 52

Licensing Intellectual Property 52

LexBlog IP

AUGUST 29, 2022

Teva announced today that the European Commission has granted marketing authorization for RANIVISIO, a biosimilar ranibizumab, for the treatment of age-related macular degeneration (AMD). Teva entered into a strategic partnership with Bioeq AG for the exclusive commercialization of ranibizumab.

Marketing 52

Marketing Marketing Licensing Reporting 52

LexBlog IP

FEBRUARY 6, 2023

STADA and Xbrane Announce Approval of Ranibizumab Biosimilar in UK On January 16, 2023, STADA Arzneimittel AG (STADA) and Xbrane Biopharyma AB (Xbrane) announced that the UK’s Medicines and Healthcare product Regulatory Agency (MHRA) has granted marketing authorization for XIMLUCI (ranibizumab), a biosimilar of LUCENTIS.

Marketing 52

Marketing Marketing Intellectual Property 52

LexBlog IP

NOVEMBER 15, 2021

Privacy of health-related information gathered by providers of healthcare services or supplies — such as physician offices and pharmacies — has long been protected by the Health Insurance Portability and Accountability Act (“HIPAA”). FTC Policy Statement.

Privacy 40

Privacy Technology Intellectual Property 40

IP and Legal Filings

MARCH 14, 2024

Introduction The main factor driving the country’s rapid adoption of corporate social responsibility is the fact that India has one of the fastest-growing economies, and socioeconomic issues like poverty, illiteracy, a lack of access to healthcare, etc. As a result, the sector of CSR is expanding quickly and becoming more competitive.

Business 92

Business Reporting Government Journalism 92

Velocity of Content

MAY 15, 2023

In 2012 in the Harvard Business Review , Thomas Davenport, an authority on data analytics, and mathematician DJ Patil, who served as first US chief data scientist, declared that data scientist would prove to be “ The Sexiest Job of the 21st Century.” They often work closely with librarians and others trained in information science.

Reporting 52

Reporting Business Technology Copyright 52

The IPKat

FEBRUARY 16, 2024

For example, under ‘eliminating hunger’ the class would explore patented seeds, and medical drugs as part of the ‘good healthcare’ task, all of which get the students to think about power imbalance, private and public funding, and questions of where ownership of key commodities should lie.

Intellectual Property Law 113

Intellectual Property Law Intellectual Property Law Non-Fungible Tokens 113

SpicyIP

OCTOBER 9, 2021

The pandemic has put into perspective the lack of access to effective healthcare that many people across the globe have to face. The right to life and healthcare being one of the most fundamental of human rights naturally intertwines the two fields in this discussion.

Intellectual Property 116

Intellectual Property Intellectual Property Law Higher Education Registration 116

LexBlog IP

AUGUST 9, 2021

As the world came to a screeching halt, healthcare providers and essential businesses were tasked with maintaining function while protecting patients, employees, and customers amidst a rapidly changing health and technological landscape. emergency period.”

Licensing 52

Licensing Technology Law Confidentiality 52

IP and Legal Filings

SEPTEMBER 28, 2021

The onset of the COVID 19 pandemic has sparked discussions surrounding the role of IPR in impeding healthcare accessibility, especially in developing and underdeveloped countries. Several organizations have noted that the patenting of healthcare products and vaccines translates to a “red tape” that is uncalled for in such tumultuous times.

IP 52

IP Related Rights Patent Technology 52

IPilogue

NOVEMBER 30, 2022

As a prisoner in Auschwitz, Dina Gottliebova Babbitt was forced to author portraits of prisoners. Yet using these works with no authorization from legitimate owners is both morally and legally questionable. Yet the Keynote Address and Keynote Commentary at the Conference told a copyright story that has never been told.

Art 106

Art Copyright Moral Rights Fair Use 106

BYU Copyright Blog

AUGUST 16, 2021

On August 10, 2021, healthcare chaplain Barry D. Following the Plaintiff's initial seminar, he claims that the Defendants began to reproduce, distribute, and publicly display his plan without his authority. the complaint, the Plaintiff provides background on how he came to know and interact with the Defendants.

Plagiarism 52

Plagiarism Copyright Infringement Copyright 52

IP Intelligence

APRIL 24, 2023

Although the Copyright Office’s official guidance on whether you can be the author of AI output is a solid “maybe?,” Consistent with the Copyright Office’s guidance in the Compendium, Third Edition, there is often “creative input or intervention from a human author” at multiple steps in the process.

Ownership 98

Ownership Copyright Public Domain Registration 98

LexBlog IP

OCTOBER 30, 2023

The NIST standards will likely build on its prior work as published in its AI Risk Management Framework Biological synthesis screening – to protect against the risks of using AI to engineer dangerous biological materials, strong new standards for biological synthesis screening will be developed by agencies that fund life-science projects as a (..)

Privacy 52

Privacy Government Intellectual Property Copyright 52

Biswajit Sarkar Copyright Blog

MARCH 1, 2024

Healthcare: Research in biotechnology firms revolutionizes the healthcare system. Here, genetically modified strains of microorganisms can be patented, but the strain must be deposited to the international depository authority before patent application.

Patent 92

Patent Inventor Invention Intellectual Property 92

IIPRD

APRIL 2, 2024

xi] Many of the medications and treatments that are essential to the world’s healthcare system are produced by these companies. Author : Ipsita Sarkar, in case of any queries please contact/write back to us via email to chhavi@khuranaandkhurana.com or at IIPRD. [i] i] World Trade Organization, [link] (last visited Mar.

Intellectual Property 105

Intellectual Property Branding Brands Branding 105

LexBlog IP

AUGUST 2, 2021

Citing to a recent report of security incidents and data breaches in the healthcare sector, OCR noted that 61 percent of analyzed data breaches were perpetrated by external threat actors and 39 percent by insiders.

Government 52

Government Reporting Business Intellectual Property 52

LexBlog IP

MARCH 12, 2023

The Cybercrime Law is extremely strict when it comes to breach of government data, or information that is confidential, or related to banking, healthcare, media, or a scientific entity, and therefore, the penalties are more severe.

Government 40

Government Publishing Confidentiality Law 40

TorrentFreak

FEBRUARY 6, 2023

Authorities located Canadian Gary Bowser in the Dominican Republic and arrested him there. While I’m in Canada I’m going to try to get that dome because Canada has a good public healthcare system. In the fall of 2020, the U.S. Meanwhile, Frenchman Max Louarn was detained in Tanzania.

Government 131

Government Copying Publishing Reporting 131

SpicyIP

JULY 28, 2022

He was earlier associated with Cadila Healthcare (currently – Zydus Lifesciences). Author: Amit Tailor. . rather the post focus on the reasoning provided, and the authority relied upon, by the Hon’ble Court to allow the appeal and thereby the amendments. This reliance on Konica and drawing authority therefrom based on the Art.

Patent Application 105

Patent Application Patent Art Reporting 105

43(B)log

JUNE 17, 2022

In its contempt motion, ExeGi identified three relevant violations: (1) a letter Alfasigma sent to healthcare providers, (2) comments on Facebook, and (3) a press release. The letter to healthcare providers was posted on Alfasigma’s website before the court issued the permanent injunction.

False Advertising 64

False Advertising Advertising Advertising Litigation 64

Patently-O

MAY 31, 2023

The evidence shows women are less frequently credited as authors on articles and patents, a pattern echoing historical instances like Rosalind Franklin’s unacknowledged work on the DNA structure and Jennifer Doudna’s worries about diminished recognition in the CRISPR development.

Inventor 105

Inventor Invention Intellectual Property Business 105